Citation
Karp P.D. Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Designin Drug Metabolism Databases and High-Throughput Testing During Drug Design and Development, Blackwell Science Ltd, 1997.
Use of Metabolic Databases to Guide Target Selection for Anti-Microbial Drug Design
Read more from SRI
-
SRI completes Global Startup Campus team: Directors appointed
Cabinet Office and Japan Science and Technology Agency approve David Schwartz and Kenji Yoshihira to lead research themes under Japan’s Global Startup Campus Initiative.
-
SRI appoints Robert Mandelbaum as Senior Vice President of Strategic Initiatives
Former Lockheed Martin ATL Managing Director and DARPA Program Manager to lead institute-wide high-growth programs.
-
SRI-spinout Wingsure helps coffee farms build consistent intelligence
The new smartphone platform gives growers a single, verified record across various programs.